Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 84 of 297
- RecruitingPhase 2/Phase 3
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
Takeda
- Location
- Chula Vista, CA + 16 other US sites
- Eligibility basics
- Ages 18–71
- RecruitingPhase 1/Phase 2
ATR 1072 in Participants With PRKAG2 Syndrome
Atrium Therapeutics
- Location
- Kansas City, MO
- Eligibility basics
- Ages 18–65
- Recruiting
Device for Treating Generalized Anxiety
BTL Industries Ltd.
- Location
- Denver, CO + 2 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2/Phase 3
Corneal Crosslinking for Treatment of Corneal Neovascularization
Price Vision Group
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18+
- Recruiting
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
Herrick Medical LLC
- Location
- Hackensack, NJ
- Eligibility basics
- Ages 50–100
- Recruiting
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Pulmonx Corporation
- Location
- Phoenix, AZ + 17 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
JenaValve Technology, Inc.
- Location
- Burlingame, CA + 33 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Pulsed Electromagnetic Field Treatment With Dementia Patients
Herrick Medical LLC
- Location
- Boca Raton, FL
- Eligibility basics
- Ages 50–100
- RecruitingPhase 2
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
- Location
- Grand Junction, CO + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Arcadia, CA + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
iCell Gene Therapeutics
- Location
- New Hyde Park, NY
- Eligibility basics
- Ages 16–70
- RecruitingPhase 3
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Transcend Therapeutics
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Clinical Outcomes of 3D Printed and Milled Complete Dentures
Dentsply Sirona Implants and Consumables
- Location
- Chapel Hill, NC
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)
KalVista Pharmaceuticals, Ltd.
- Location
- Colorado Springs, CO
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Amgen
- Location
- Long Beach, CA + 2 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)
Vaderis Therapeutics AG
- Location
- Chicago, IL + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Thermoregulatory Physiology of Menopausal Hot Flashes
SRI International
- Location
- Menlo Park, CA
- Eligibility basics
- Ages 40–65 · Women only
- Recruiting
A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort
Signal Relief
- Location
- Meadowbrook, PA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 4
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
AstraZeneca
- Location
- Las Vegas, NV
- Eligibility basics
- Ages 18–130 · Women only
- RecruitingPhase 1
PT150 Drug for Use in Alcohol Use Disorder
Pop Test Oncology LLC
- Location
- Lexington, KY
- Eligibility basics
- Ages 21–55
- RecruitingPhase 2
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
ARS Pharmaceuticals, Inc.
- Location
- Glenview, IL + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Birmingham, AL + 117 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 1
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder
AbbVie
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–65
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies